Merck to Study Health Risks of Zilmax Cattle Hormone

Following renewed concerns about the potential side effects of Zilmax given to cattle, Merck has announced that it will launch a study that is focused on the health risks of the popular cattle supplement.  

A week after Tyson Foods, the nation’s largest meat processor, announced that it will no longer accept beef from cattle treated with Zilmax, the manufacturer of the supplement has launched a study on the popular beef beta-agonist supplement. Merck & Co. announced the investigation on August 8.

Tyson said their decision came after cattle that had been given Zilmax were observed having difficulty walking and moving. The final decision was based on animal welfare, and not made for health concerns, reports the company. While they are not certain what causes of the reported lameness, some experts point to Zilmax.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

Zilmax is a popular beta-agonist, a class of drug used to add weight to cattle, pigs and turkey before slaughter. It is given to the animal for only 20 days, but Merck reports the product increases carcass weight by 24 to 33 pounds, while improving tenderness and flavor in the beef.

The FDA approved Zilmax and it has been used for nearly two decades in many countries around the world, including the U.S., Mexico, South Africa and South Korea. Merck promotes Zilmax as a way to produce more beef with fewer cattle, while conserving natural resources by using less water and energy.

“We are confident that, based on all of the available data on Zilmax, the experience reported by Tyson is not attributable to Zilmax,” Merck said in its announcement. “Indeed, Tyson itself points to the fact that there are other possible causes and that it does not know the specific cause of the issues it recently experienced.”

The announcement of the study into the potential Zilmax health risks includes a plan to increase quality control and proper customer use. Merck will launch an additional five part training program which will focus on answering questions regarding possible negative effects of the drug.

The program will require cattle feeders and feed lot operators to undergo additional training. Another part of the program is a scientific audit which will follow the cattle from feed yards to packing plants. Researchers hope to determine the potential causes of lameness in the cattle.

At a recent Denver conference, JBS USA, a large U.S. cattle processor, showed video of cattle with signs of lameness and having difficulty walking after being fed beta-agonist additives. JBS USA is also a large U.S. cattle processor.

Rumors mounted following the announcements, including allegations that many cattle companies are being offered premium prices by Tyson for cattle which have never been fed Zilmax. Tyson representatives say they only offer premium prices for cattle which meet criteria of their Open Prairie Natural Angus Beef Program. The program only accepts beef from cattle which did not receive hormones, antibiotics or beta-agonists.

Tyson suppliers will be given a choice to switch to a different beta-agonist or to stop offering cattle fed Zilmax completely. Critics say many rivals will likely follow suit and begin phasing out Zilmax as well.

Tags: Merck, Zilmax
Image Credit: |


Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Baby Food Injury Lawyers Appointed To Leadership Roles in Autism, ADHD Lawsuits Over Heavy Metal Contamination
Baby Food Injury Lawyers Appointed To Leadership Roles in Autism, ADHD Lawsuits Over Heavy Metal Contamination (Posted yesterday)

A group of 19 plaintiffs' lawyers have been appointed to serve in various leadership position during the consolidated pretrial proceedings for all baby food injury lawsuits, taking actions that benefit all families pursuing claims for children diagnosed with autism, ADHD or other developmental problems from toxic heavy metals found in many popular products sold in recent years.

Court Allows Suboxone Tooth Decay Lawsuits To Be Filed in Bundled Complaint by June 14, 2024
Court Allows Suboxone Tooth Decay Lawsuits To Be Filed in Bundled Complaint by June 14, 2024 (Posted 4 days ago)

A federal judge is allowing plaintiffs to file large numbers of Suboxone tooth decay lawsuits in one bundled complaint, to meet a potential two-year statute of limitations deadline, with the ability to flesh those claims out in more detail at a later date.